Eli Lilly: Studies suggest key correlation between lung cancer subtype and treatment outcomes
September 26th, 2007
Co In clinical research, patients with advanced non-small cell lung cancer that are classified as having a non-squamous histology achieve statistically significant higher survival when treated in the second-line setting with ALIMTA (pemetrexed for injection) when compared to histologically-similar patients treated with docetaxel.